In the 44th week of the year, Anna Popova of Russia’s Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing flagged a concerning shift in the respiratory illness landscape. Surveillance data shows a seasonal rise in ARVI, with flu now accounting for nearly 5% of circulating viruses – specifically the A(H1N1) strain. This variant has not been present in previous flu seasons and was not included in this year’s vaccines.

"We see a seasonal growth in ARVI, and the proportion of flu is rising," Popova said. "Nearly 5% of all viruses we register are influenza A(H1N1). And this confirms our forecast that flu will be. Flu is not simple, because we are not protected from it. This variant of the flu did not exist in previous years, did not circulate, and was not used in vaccines."
In just one week, Russia recorded over 555,000 cases of acute respiratory viral infections, flu, and COVID-19. The incidence is climbing weekly, signaling a broad uptick in respiratory illness across the country.
The campaign remains ongoing as health authorities monitor the circulating strain.
The national vaccination campaign has progressed significantly. Over 35.4 million citizens have already been vaccinated against the flu. The campaign remains ongoing as health authorities monitor the circulating strain.
"Now is the time to get vaccinated," Popova urged, noting the importance of timely immunization amid the new strain’s circulation.
As the season progresses, focus remains on containment and monitoring. The numbers will continue to be tracked, and public health authorities continue to urge vaccination as part of the response.
